BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7906861)

  • 21. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
    Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
    Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.
    Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI
    Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance.
    Goustin AS; Abou-Samra AB
    Cell Signal; 2011 Jun; 23(6):980-90. PubMed ID: 21087662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
    Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
    Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes.
    Miura A; Kajita K; Ishizawa M; Kanoh Y; Kawai Y; Natsume Y; Sakuma H; Yamamoto Y; Yasuda K; Ishizuka T
    Metabolism; 2003 Jan; 52(1):19-24. PubMed ID: 12524657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
    Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.
    Luo M; Reyna S; Wang L; Yi Z; Carroll C; Dong LQ; Langlais P; Weintraub ST; Mandarino LJ
    Endocrinology; 2005 Oct; 146(10):4410-6. PubMed ID: 16020478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function.
    Liu F; Roth RA
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10287-91. PubMed ID: 7479769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.
    Costantino A; Milazzo G; Giorgino F; Russo P; Goldfine ID; Vigneri R; Belfiore A
    Mol Endocrinol; 1993 Dec; 7(12):1667-76. PubMed ID: 8145772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive and negative elements modulate the promoter of the human liver-specific alpha2-HS-glycoprotein gene.
    Banine F; Gangneux C; Mercier L; Le Cam A; Salier JP
    Eur J Biochem; 2000 Feb; 267(4):1214-22. PubMed ID: 10672033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the pp63 gene encoding the insulin receptor tyrosine kinase inhibitor in proliferating liver and in liver tumors.
    Colombo BM; Falquerho L; Manenti G; Dragani TA; Le Cam A
    Biochem Biophys Res Commun; 1991 Oct; 180(2):967-71. PubMed ID: 1659407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
    Belfiore A; Costantino A; Frasca F; Pandini G; Mineo R; Vigneri P; Maddux B; Goldfine ID; Vigneri R
    Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin.
    Haasemann M; Nawratil P; Müller-Esterl W
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):899-902. PubMed ID: 1707273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.
    Maddux BA; Goldfine ID
    Diabetes; 2000 Jan; 49(1):13-9. PubMed ID: 10615944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor.
    Rauth G; Pöschke O; Fink E; Eulitz M; Tippmer S; Kellerer M; Häring HU; Nawratil P; Haasemann M; Jahnen-Dechent W
    Eur J Biochem; 1992 Mar; 204(2):523-9. PubMed ID: 1371750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rat protein encoded by clone pp63 is a fetuin/alpha 2-HS glycoprotein-like molecule, but is it the tyrosine kinase inhibitor pp63?
    Brown WM; Christie DL; Dziegielewska KM; Saunders NR; Yang F
    Cell; 1992 Jan; 68(1):7-8. PubMed ID: 1370655
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation of alpha-fetoprotein expression in normal hepatocytes during development with tyrosine phosphorylation and insulin receptor expression.
    Khamzina L; Borgeat P
    Mol Biol Cell; 1998 May; 9(5):1093-105. PubMed ID: 9571242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site.
    Kumakura S; Maddux BA; Sung CK
    J Cell Biochem; 1998 Mar; 68(3):366-77. PubMed ID: 9518262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of Asn281 in the alpha-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization.
    Desbois-Mouthon C; Sert-Langeron C; Magre J; Oreal E; Blivet MJ; Flori E; Besmond C; Capeau J; Caron M
    J Clin Endocrinol Metab; 1996 Feb; 81(2):719-27. PubMed ID: 8636294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.